PharVision Advisers, LLC
- SEC CIK
- 0001898824
- Latest filing
- Aug 11, 2026
BSX holding history
Boston Scientific Corp in every 13F filed by PharVision Advisers, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
BSX overviewAll 13F holders of BSXFull Q2 2026 holdings
- Shares (Q1 2026)
- 0
- Sold out in Q1 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 4
- Since Q1 2025
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2026 | 0 | $0 | 0.0% | −6,244−100.0% | Sold out | Holders |
| Q4 2025 | 6,244 | $595.4K | 0.3% | +766+14.0% | Added | Holders |
| Q3 2025 | 5,478 | $534.8K | 0.3% | +3,105+130.8% | Added | Holders |
| Q2 2025 | 2,373 | $254.9K | 0.4% | −1,436−37.7% | Reduced | Holders |
| Q1 2025 | 3,809 | $384.3K | 0.5% | +3,809 | New | Holders |